Myeloma and Related Diseases Registry (MRDR)

You are invited to the MRDR webinar at the National Myeloma Workshop (NMW). Saturday, 5 September. Time: 4-5 pm AEST. You need to register for this free double event. For registration, program and NMW details go to NEWS above. Don't miss it!

Find out more

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
3941

Patients accrued

2558

Patients with multiple myeloma

49

Number of approved sites

459

Biobank participants

Latest news

MRDR webinar at National Myeloma Workshop: 5 Sept
10 Aug 2020

We invite you to the free MRDR webinar: 5 Sept, 4-5pm

Read more
My-PROMPT trial published!
05 Apr 2020

Real-time feedback of patient-reported outcomes feasible for patients and clinicians!

Read more
COVID-19 NOTICE
20 Mar 2020

MRDR still operating during COVID-19 pandemic.

Read more
Myeloma 1000 Biobank reaches 400+ samples
03 Feb 2020

The Myeloma 1000 Biobank now has samples from over 400 patients!

Read more

Participating organisations